EPICENTRX INC
With a prolific platform of small molecule therapies, innate immune checkpoint inhibitors, cell based therapies, vaccines and oncolytic viruses, the central focus of EpicentRx Inc., a privately owned physician-led phase 3 clinical-stage immuno-oncology company located in San Diego, California, is on anticancer immunization and chemo/radioprotection of normal tissues. As a company of actively practicing oncologists/internists they at EpicentRx take cancer very very personally (in a literal and figurative sense) with the plight of the patient serving first and foremost as the motivation to customize or personalize their platform of immunotherapies both to individuals that are otherwise out of options and to groups of individuals with common and in many cases currently undruggable mutations.
EPICENTRX INC
Social Links:
Industry:
Biotechnology
Founded:
2002-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.epicentrx.com
Total Employee:
11+
Status:
Active
Contact:
(858) 947-6635
Email Addresses:
[email protected]
Total Funding:
35.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - EpicentRx Inc
Key Employee Changes
| Date | New article |
|---|---|
| 2019-12-04 | EpicentRx Appoints Senior Life Science Financial Executive Dr. Franck Brinkhaus as Chief Financial Officer |
Official Site Inspections
http://www.epicentrx.com
- Host name: webcluster2.webpod14-cph3.one.com
- IP address: 46.30.213.164
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "EpicentRx Inc"
EpicentRx Inc - Crunchbase Company Profile & Funding
With a prolific platform of small molecule therapies, innate immune checkpoint inhibitors, cell based therapies, vaccines and oncolytic viruses, the central focus of EpicentRx Inc., a โฆSee details»
Enter the Center - EpicentRx
At EpicentRx, his work focuses on the clinical translation of AdAPT-001 and the development of in-house manufacturing processes. MEAGHAN STIRN, M.B.A. Vice President of Finance & โฆSee details»
EpicentRx, Inc. - LinkedIn
EpicentRx is an innovation-driven clinical-stage drug and device company that puts the emphasis on โeaseโ - ease of treatment, ease of side effects, and ease of symptoms during the treatment ...See details»
EpicentRx Inc - Org Chart, Teams, Culture & Jobs - The Org
View EpicentRx Inc's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
EpicentRx Company Profile - Office Locations, Competitors ... - Craft
EpicentRx evolved from a cross-disciplinary collaboration between Stanford University, the aerospace contractor ATK, and the VC firm InterWest Partners, to develop small molecule, โฆSee details»
EpicentRx - Company Profile - Tracxn
Nov 27, 2024 EpicentRx, a clinical stage biotechnology company, specializing in epigenetics. EpicentRx evolved from a cross-disciplinary collaboration between Stanford University, the โฆSee details»
EpicentRx Inc - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 12, 2022: Grant - โฆSee details»
EpicentRx Inc - Contacts, Employees, Board Members
EpicentRx Inc has 5 current employee profiles, including Head of Business Development Babak N. Alizadeh. Babak N. Alizadeh Head of Business Development Bryan Oronsky Chief Medical โฆSee details»
EpicentRx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
The Translational Research Award, funded through the CDMRP Toxic Exposures Research Program (TERP), will fund research at both EpicentRx and QUT-TRI in Brisbane, Australia to โฆSee details»
EpicentRx - VentureRadar
EpicentRx is a leading-edge biopharmaceutical company with a complementary pipeline of small molecule and cancer targeting virus platforms that represent the next frontier in treating โฆSee details»
EpicentRx, Inc. in an Expansive Growth Phase
Jan 6, 2021 EpicentRx is a clinical stage immuno-oncology company focused on the development of minimally toxic therapeutics for the treatment of cancer. EpicentRxโs phase 3 โฆSee details»
News - EpicentRx
May 15, 2024 June 2023; Chicago, Illinois Poster: RRX-001 Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß โฆSee details»
EpicentRx CEO and Key Executive Team | Craft.co
EpicentRx's President & Chief Financial Officer is Franck Brinkhaus. Other executives include Tony Reid, Chief Executive Officer, Chief Strategy Officer; Bryan Oronsky, Chief Development โฆSee details»
EpicentRx - Overview, News & Similar companies | ZoomInfo.com
EpicentRx contact info: Phone number: (858) 947-6635 Website: www.epicentrx.com What does EpicentRx do? Headquartered in La Jolla, California, EpicentRx is a company that focuses on โฆSee details»
EpicentRx Awarded Grant from The Michael J. Fox Foundation to โฆ
Jul 12, 2022 The $500,000 USD grant will support study of EpicentRx's lead small molecule inflammasome inhibitor. TORREY PINES, Calif., July 12, 2022 /PRNewswire/ --EpicentRx Inc. โฆSee details»
EpicentRx Announces Oral Presentation for the Most Clinically โฆ
May 23, 2024 Lead EpicentRx therapy, AdAPT-001, is the most clinically advanced TGF-ฮฒ ligand trap that antagonizes the immunosuppressive effects of TGF-ฮฒ and augments โฆSee details»
New industry partnership to accelerate development of
BRISBANE, AUSTRALIA, July 12, 2022 โ University of Queensland researchers will partner with American biopharmaceutical company EpicentRx Inc. to evaluate new treatments for โฆSee details»
IO, IO, Itโs Off To Work We Go - EpicentRx
Jul 17, 2024 The IO from the title stands for immune-oncology. This term, IO, refers to therapies that mobilize the immune system to recognize and eradicate tumor cells. Instead of 7 dwarfs, โฆSee details»
What is EpicentRx? Company Culture, Mission, Values
See what employees say it's like to work at EpicentRx. Salaries, reviews, and more - all posted by employees working at EpicentRx.See details»
Underconsumption Core - EpicentRx
Aug 21, 2024 The latest craze on TikTok with over 31M views is called #underconsumptioncore. This long and unwieldy phrase ironically champions/romanticizes an ethos of minimalism, โฆSee details»